Health system’s second-quarter financials mixed
[ad_1] Labor costs, driven by demand for contract workers amid staff shortages, were the hot topic in the hospital industry’s second-quarter earnings reports. Health system are doling out higher pay
[ad_1] Labor costs, driven by demand for contract workers amid staff shortages, were the hot topic in the hospital industry’s second-quarter earnings reports. Health system are doling out higher pay
[ad_1] ‘Single biggest investment in climate change in US history’ The bill would invest $369 billion over the decade in climate change-fighting strategies including investments in renewable energy production and
[ad_1] SCAN Group plans to expand its Medicare Advantage reach into Texas in 2023 as the insurer stakes its claim in another competitive market for private Medicare plans. In addition
[ad_1] Allscripts Healthcare Solutions on Thursday posted a nearly 7% rise in year-over-year second-quarter revenue as it continues to refocus its business on its payer and life sciences division, Veradigm.
[ad_1] Health Care Service Corp. plans to expand its Medicare Advantage business into another 150 counties next year as the insurer seeks to gain a foothold in an increasingly competitive
[ad_1] The number of people living in America without health insurance coverage hit an all-time low of 8 percent this year, the US Department of Health and Human Services announced
[ad_1] The Justice Department on Tuesday filed a lawsuit that challenges Idaho’s restrictive abortion law, arguing that it conflicts with a federal law requiring doctors to provide pregnant women medically
[ad_1] Medicare payments for hospital inpatient services will rise 4.3% in fiscal 2023 under a final rule the Centers for Medicare and Medicaid Services published Monday. That amounts to (A)
[ad_1] Nursing homes will receive a net $904 million increase in Medicare payments during fiscal 2023 under a final rule the Centers for Medicare and Medicaid Services issued Friday. In
[ad_1] The Biden administration said Friday it has reached an agreement with Moderna to buy 66 million doses of the company’s next generation of COVID-19 vaccine that targets the highly